Transforming growth factor 1 inhibits aldosterone and cortisol production in the human adrenocortical cell line NCI-H295R through inhibition of CYP11B1 and CYP11B2 expression
暂无分享,去创建一个
G. Defaye | P. Liakos | D. Lenz | R. Bernhardt | J-J Feige
[1] S. Portrat,et al. Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11beta-hydroxylase) and CYP11B2(aldosterone synthase) cause steroid 11beta-hydroxylase deficiency and congenital adrenal hyperplasia. , 2001, The Journal of clinical endocrinology and metabolism.
[2] Yasuo Suzuki,et al. A primary adrenal steroid, 11β-hydroxyandrostenedione, has an osteotropic effect and little androgenic activity , 2000, The Journal of Steroid Biochemistry and Molecular Biology.
[3] G. Arnaldi,et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. , 2000, The Journal of clinical endocrinology and metabolism.
[4] E. Chambaz,et al. Transcriptional Regulation of the Gene Encoding the Star Protein in the Human Adrenocortical Cell Line, H295R by Camp and Tgfß1 , 2000, Endocrine research.
[5] C. Gicquel,et al. Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line. , 1999, Journal of molecular endocrinology.
[6] P. De Giuli,et al. Different immunohistochemical patterns of TGF‐β1 expression in benign and malignant adrenocortical tumours , 1999, Clinical endocrinology.
[7] W. Rainey. Adrenal zonation: clues from 11β-hydroxylase and aldosterone synthase , 1999, Molecular and Cellular Endocrinology.
[8] W. Sippell,et al. Disorders of the Aldosterone Synthase and Steroid 11β-Hydroxylase Deficiencies , 1999, Hormone Research in Paediatrics.
[9] E. Chambaz,et al. Smad3 is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on StAR expression. , 1998, Biochemical and biophysical research communications.
[10] C. Heldin,et al. Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer* , 1998, The Journal of Biological Chemistry.
[11] Denis Vivien,et al. Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.
[12] E. Chambaz,et al. Transforming Growth Factor β1 Decreases Cholesterol Supply to Mitochondria via Repression of Steroidogenic Acute Regulatory Protein Expression* , 1998, The Journal of Biological Chemistry.
[13] D. Rifkin,et al. Latent transforming growth factor-beta: structural features and mechanisms of activation. , 1997, Kidney international.
[14] C. Le Roy,et al. Repression of Transforming Growth Factor 1 Protein by Antisense Oligonucleotide-induced Increase of Adrenal Cell Differentiated Functions (*) , 1996, The Journal of Biological Chemistry.
[15] D. Naville,et al. Effects of transforming growth factor-beta 1 on human adrenocortical fasciculata-reticularis cell differentiated functions. , 1994, The Journal of clinical endocrinology and metabolism.
[16] I. Bird,et al. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies , 1994, Molecular and Cellular Endocrinology.
[17] A. Stanković,et al. Effects of transforming growth factor-β on human fetal adrenal steroid production , 1994, Molecular and Cellular Endocrinology.
[18] J. Mathis,et al. Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion. , 1993, Endocrinology.
[19] N. Hanley,et al. Regulation of human adrenal carcinoma cell (NCI-H295) production of C19 steroids. , 1993, The Journal of clinical endocrinology and metabolism.
[20] J. Mathis,et al. Angiotensin increases aldosterone synthase mRNA levels in human NCI-H295 cells , 1993, Molecular and Cellular Endocrinology.
[21] D. Hum,et al. Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal. , 1993, Molecular endocrinology.
[22] J. Connell,et al. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[23] L. Gentry,et al. Transforming growth factor-beta 1 inhibits aldosterone and stimulates adrenal renin in cultured bovine zona glomerulosa cells. , 1992, Endocrinology.
[24] T. Triche,et al. Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. , 1990, Cancer research.
[25] W. Rainey,et al. Transforming growth factor beta treatment decreases ACTH receptors on ovine adrenocortical cells. , 1989, The Journal of biological chemistry.
[26] E. Chambaz,et al. Effects of transforming growth factor beta on ovine adrenocortical cells , 1988, Molecular and Cellular Endocrinology.
[27] A. Baird,et al. The inhibition of low density lipoprotein metabolism by transforming growth factor-beta mediates its effects on steroidogenesis in bovine adrenocortical cells in vitro. , 1987, Endocrinology.
[28] A. Baird,et al. Differential effects of transforming growth factor type beta on the growth and function of adrenocortical cells in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[29] E. Chambaz,et al. Type beta transforming growth factor is a potent modulator of differentiated adrenocortical cell functions. , 1986, Biochemical and biophysical research communications.
[30] P. White. Steroid 11 beta-hydroxylase deficiency and related disorders. , 2001, Endocrinology and metabolism clinics of North America.
[31] A. Balmain,et al. TGF-beta signaling in tumor suppression and cancer progression. , 2001, Nature genetics.
[32] E. Baudin,et al. Establishment and characterization of a human adrenocortical carcinoma xenograft model. , 2000, Endocrinology.
[33] E. Chambaz,et al. Differential implication of StAR and P450c17 in TGFbeta1-induced decrease of adrenocortical steroidogenesis. , 1998, Endocrine research.
[34] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[35] C. Falany,et al. Effects of ACTH and cytokines on dehydroepiandrosterone sulfotransferase messenger RNA in human adrenal cells. , 1998, Endocrine research.
[36] E. Chambaz,et al. Oxygen availability as a regulatory factor of androgen synthesis by adrenocortical cells. , 1993, Endocrinology.
[37] E. Chambaz,et al. Transforming growth factor beta 1 is a negative regulator of steroid 17 alpha-hydroxylase expression in bovine adrenocortical cells. , 1991, Endocrinology.
[38] J. Feige,et al. Growth factor regulation of adrenal cortex growth and function. , 1991, Progress in growth factor research.
[39] E. Chambaz,et al. Transforming growth factor beta 1: an autocrine regulator of adrenocortical steroidogenesis. , 1991, Endocrine research.
[40] R. Magness,et al. Transforming growth factor-beta inhibits steroid 17 alpha-hydroxylase cytochrome P-450 expression in ovine adrenocortical cells. , 1990, Endocrinology.
[41] M. Sporn,et al. Transforming growth factors (TGFs): properties and possible mechanisms of action. , 1981, Journal of supramolecular structure and cellular biochemistry.